(Philadelphia, PA) – Eli. J. Glatstein, MD, Professor and Vice Chair of Radiation Oncology at the University of Pennsylvania School of Medicine, has been named a 2004 Gold Medal recipient by The American Society for Therapeutic Radiology and Oncology (ASTRO). Dr. Glatstein, who also serves as a member of the Abramson Cancer Center of the University of Pennsylvania, is being honored for his more than 35 years of dedicated service in the field of radiation oncology at the Society's annual national meeting to be held in Atlanta on October 4, 2004.
Much of Dr. Glatstein's work has made a significant impact on how different cancers are diagnosed and treated. His research significantly improved how physicians stage and treat cancer, particularly Hodgkin's disease. But it was in the early 1970's -- while working as Chief of the Radiation Oncology Branch of the Clinical Oncology Program in the Division of Cancer Treatment at the National Cancer Institute -- that Dr. Glatstein successfully integrated different modalities of cancer treatment by combining radiation oncology with medical oncology. This essentially changed the stature of radiation oncology within the general cancer community itself.
"Dr. Glatstein's career has been marked by several milestones," said John H. Glick, MD, Director of Penn's Abramson Cancer Center. "It is through his pioneering efforts and dedication that physicians have been able to successfully diagnose and treat many cancers, such as Hodgkin's disease, with such precision. Dr. Glatstein represents the high caliber of physician-scientists working every day in service to others at the Abramson Cancer Center of the University of Pennsylvania."
Dr. Glatstein's long and impressive career began in 1960 when he graduated summa cum laude with a Bachelor of Arts degree in General Science from the State University of Iowa. He then went on to earn his medical degree from Stanford University School of Medicine. His post-graduate training included an internship at New York Hospital in 1965. As the Vietnam War entered its sixth year, Dr. Glatstein was drafted and spent a year of active duty in the Republic of South Vietnam and another year stationed at the Oakland Army Base in California. He would eventually be awarded the Bronze Star for his efforts during active combat. After serving in the military, he returned to academic life and completed his Residency and Fellowship in Radiation Therapy at Stanford University School of Medicine. Dr. Glatstein also spent some time abroad finishing fellowships at Hammersmith Hospital and the Gray Laboratory at Mount Vernon Hospital in the United Kingdom.
He started his teaching career as an Assistant Professor of Radiology at Stanford University School of Medicine in 1972. He left that post in 1979 for the Uniformed Services University for Health Services in Bethesda, Maryland where he rose through the ranks to become a full Professor of Radiology. In 1982 Dr. Glatstein arrived at The University of Texas Southwestern Medical Center in Dallas where he served in the Department of Radiation Oncology as Professor and Chairman. In 1996, he left this post to become a Professor and Vice Chairman of the Department of Radiation Oncology at Penn.
ASTRO is the largest radiation oncology society in the world, with more than 7,500 members who specialize in treating patients with radiation therapies. As a leading organization in radiation oncology, biology and physics, the Society is dedicated to the advancement of the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving socioeconomic healthcare environment. The ASTRO Annual Meeting typically draws 9,000 healthcare professionals and exhibitors.
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.
The art of medicine consists in amusing the patient while nature cures the disease.